Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene

NCT05642871 is registered in ClinicalTrials.gov with Qianqian Qu as lead sponsor.

NCT NCT05642871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05642871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene
Lead sponsor
Qianqian Qu
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2023
Completion date
August 31, 2025
Enrollment
2 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumor of the ovary, xrcc2 gene mutation